CARTA, DAVIDE
 Distribuzione geografica
Continente #
NA - Nord America 3.562
AS - Asia 1.424
EU - Europa 1.062
AF - Africa 309
SA - Sud America 293
OC - Oceania 49
Continente sconosciuto - Info sul continente non disponibili 19
Totale 6.718
Nazione #
US - Stati Uniti d'America 3.373
SG - Singapore 465
CN - Cina 387
IT - Italia 272
BR - Brasile 183
HK - Hong Kong 182
FI - Finlandia 113
DE - Germania 111
PL - Polonia 77
VN - Vietnam 57
SE - Svezia 54
NL - Olanda 50
FR - Francia 39
RU - Federazione Russa 34
IN - India 28
TR - Turchia 21
GB - Regno Unito 20
IE - Irlanda 20
KR - Corea 20
UA - Ucraina 19
AR - Argentina 17
MX - Messico 17
PA - Panama 17
IS - Islanda 16
PY - Paraguay 16
AZ - Azerbaigian 15
CA - Canada 15
CH - Svizzera 15
ES - Italia 15
GT - Guatemala 15
JP - Giappone 15
UZ - Uzbekistan 15
BO - Bolivia 14
CI - Costa d'Avorio 14
CR - Costa Rica 14
CZ - Repubblica Ceca 14
LC - Santa Lucia 14
SN - Senegal 14
AU - Australia 13
CW - ???statistics.table.value.countryCode.CW??? 13
DZ - Algeria 13
IQ - Iraq 13
TH - Thailandia 13
BJ - Benin 12
JO - Giordania 12
NO - Norvegia 12
AT - Austria 11
BG - Bulgaria 11
BY - Bielorussia 11
EG - Egitto 11
GA - Gabon 11
HR - Croazia 11
MG - Madagascar 11
MY - Malesia 11
NI - Nicaragua 11
PT - Portogallo 11
TZ - Tanzania 11
ZA - Sudafrica 11
CO - Colombia 10
DO - Repubblica Dominicana 10
GH - Ghana 10
HN - Honduras 10
ML - Mali 10
MR - Mauritania 10
NC - Nuova Caledonia 10
PE - Perù 10
PK - Pakistan 10
RS - Serbia 10
TJ - Tagikistan 10
VE - Venezuela 10
WS - Samoa 10
AE - Emirati Arabi Uniti 9
AF - Afghanistan, Repubblica islamica di 9
BA - Bosnia-Erzegovina 9
BZ - Belize 9
CU - Cuba 9
DK - Danimarca 9
EC - Ecuador 9
GF - Guiana Francese 9
ID - Indonesia 9
JM - Giamaica 9
KZ - Kazakistan 9
LB - Libano 9
LU - Lussemburgo 9
SI - Slovenia 9
UG - Uganda 9
ZW - Zimbabwe 9
AD - Andorra 8
CL - Cile 8
EE - Estonia 8
ET - Etiopia 8
IL - Israele 8
IR - Iran 8
KH - Cambogia 8
MK - Macedonia 8
MU - Mauritius 8
MW - Malawi 8
NE - Niger 8
PS - Palestinian Territory 8
TN - Tunisia 8
Totale 6.408
Città #
Fairfield 444
Ashburn 285
Chandler 278
Woodbridge 273
Singapore 272
Houston 238
Ann Arbor 224
Hong Kong 174
Seattle 171
Wilmington 158
Cambridge 147
Beijing 105
Santa Clara 95
Boardman 88
Bytom 61
Jacksonville 58
Princeton 58
Padova 53
Helsinki 52
Medford 48
San Diego 45
Des Moines 43
Los Angeles 39
Nanjing 39
Roxbury 33
Dong Ket 29
Hefei 27
Munich 24
Chicago 21
Dublin 17
Guangzhou 17
Shenyang 16
São Paulo 16
Baku 15
Naples 15
Panama City 15
Castries 14
Reykjavik 14
Tashkent 14
Abidjan 13
Changsha 13
Dakar 13
Shanghai 13
Amman 12
Seoul 12
Turku 12
Willemstad 12
Managua 11
San José 11
Accra 10
Antananarivo 10
Apia 10
Buffalo 10
Jinan 10
Libreville 10
New York 10
Noumea 10
Bamako 9
Boston 9
Cotonou 9
Dallas 9
Dushanbe 9
Falkenstein 9
Harare 9
Kampala 9
Andorra la Vella 8
Cayenne 8
Guatemala City 8
Hanoi 8
Kuala Lumpur 8
Lilongwe 8
Luxembourg 8
Minsk 8
Niamey 8
Nouakchott 8
Phnom Penh 8
Redondo Beach 8
Sofia 8
Vienna 8
Bangkok 7
Chennai 7
Dar es Salaam 7
Hebei 7
Istanbul 7
Kunming 7
La Paz 7
Ljubljana 7
Milan 7
Prague 7
Rio de Janeiro 7
Santo Domingo 7
Sydney 7
Tbilisi 7
Tianjin 7
Warsaw 7
Bishkek 6
Brooklyn 6
Cagliari 6
Ferrara 6
Ho Chi Minh City 6
Totale 4.263
Nome #
Radiofarmaci "metal based" nella cardiologia nucleare e nell'imaging tumorale 267
Evaluating the effects of fluorine on biological properties and metabolic stability of some antitubulin 3-substituted 7-phenyl-pyrroloquinolinones 229
Synthesis, structure-activity relationships and biological evaluation of 7-phenyl-pyrroloquinolinone 3-amide derivatives as potent antimitotic agents 214
Targeting tubulin polymerization by novel 7-aryl-pyrroloquinolinones: Synthesis, biological activity and SARs 208
Targeting RORs nuclear receptors by novel synthetic steroidal inverse agonists for autoimmune disorders 192
Avidin–biotin system: a small library of cysteine biotinylated derivativesdesigned for the [99mTc(N)(PNP)]2+ metal fragment 188
99mTc(N)-DBODC(5), a potential radiolabeled probe for SPECT of multidrug resistance: in vitro study 188
EB-3D a novel choline kinase inhibitor induces deregulation of the AMPK-mTOR pathway and apoptosis in leukemia T-cells 185
Synthesis and preliminary anti-inflammatory and anti-bacterial evaluation of some diflunisal aza-analogs 183
Novel 3-Substituted 7-Phenylpyrrolo[3,2-f]quinolin-9(6H)-ones as Single Entities with Multitarget Antiproliferative Activity 174
Method for optimizing coating properties based on an evolutionary algorithm approach 172
Melanoma targeting with [99mTc(N)(PNP3)]-labeled α-melanocyte stimulating hormone peptide analogs: Effects of cyclization on the radiopharmaceutical properties 171
Design, synthesis, and photophysical properties of pyrroloquinoline-based compounds showing strong blue fluorescence as potential dyes for biomedical applications 166
Pharmacological characterization of α-MSH-derivatives 160
Synthesis, characterization and biological evaluation of [188Re(N)(cys-)(PNP)]+/0 mixed-ligand complexes as prototypes for the development of 188Re(N)-based target-specific radiopharmaceuticals 159
Synthesis of new pyrrolo-, and pyrido-anellated quinazolinones as potential antiproliferative agents 151
Peroxisome proliferator-activated receptor-γ mediates the anti-inflammatory effect of 3-hydroxy-4-pyridinecarboxylic acid derivatives: Synthesis and biological evaluation 146
99mTc(N)(DASD)(pnpn)]+ (DASD=1,4-dioxa-8-azaspiro[4,5]decandithiocarba pnpn=bisphosphinoamine) for myocardial imaging 140
Amidic Coupling in the Synthesis of Pyrroloquinoline 4- and 9-Carboxamides as Potential STAT3 Inhibitors 137
Studies of new [Tc(N)(PS)]-based mixed compounds as analogues of WAY 100635 135
99mTc(N)-DBODC(5) from cardiology to oncology: preliminary in vitro study 133
Tc-99m(N)-DBODC(5) from cardiology to oncology: preliminary in vitro study 132
Treatment with a new peroxisome proliferator-activated receptor gamma agonist, pyridinecarboxylic acid derivative, increases angiogenesis and reduces inflammatory mediators in the heart of Trypanosoma cruzi-infected mice 130
[99mTc(N)(DBODC)(5)]+: sub-cellular distribution and metabolism studies of this new potential myocardial imaging agent 128
Assessment of the best N3− donors in preparation of [M(N)(PNP)]-based (M=99mTc-; 188Re) target-specific radiopharmaceuticals: Comparison among succinic dihydrazide (SDH), N-methyl-S-methyl dithiocarbazate (HDTCZ) and PEGylated N-methyl-S-methyl dithiocarbazate (HO2C-PEG600-DTCZ) 128
Chelating Systems for 99mTc/188Re in the Development of Radiolabeled Peptide Pharmaceuticals 127
Radiopharmacological characterization of 64Cu-labeled α-MSH analogs for potential use in imaging of malignant melanoma 124
An overview on 2-arylquinolin-4(1h)-ones and related structures as tubulin polymerisation inhibitors 123
Synthesis and biological evaluation of new [Tc(N)(PS)]-based mixed-ligand compounds useful in the design of target-specific radiopharmaceuticals: the 2-methoxyphenylpiperazine dithiocarbamate derivatives as an example 119
[Re-188(N)(cys similar to)(PNP)](+/0) mixed ligand compounds as models for target specific agents 118
Synthesis and Characterization of Novel Hexacoordinated, Asymmetrical M(III) (M = Re, 99gTc) Complexes as Models for the Development of Potential Tracers for SPECT Imaging and Radiotherapy 117
Design, Synthesis, and Structure–Activity Relationships of Azolylmethylpyrroloquinolines as Nonsteroidal Aromatase Inhibitors 115
[99mTc(N)(DBODC)(5)]+: sub-cellular distribution and metabolism studies of this new potential myocardial imaging agent 113
Insights into the failure of the potential, neutral myocardial imaging agent TcN-NOET: physicochemical identification of by-products and degradation species 108
Biological in vitro and in vivo studies of a series of new asymmetrical cationic [99mTc(N)(DTC-Ln)(PNP)]+ complex (DTC-Ln = alicyclic dithiocarbamate, PNP = diphosphinoamine) 106
Design and synthesis of azolylmethyl-pyrroloquinolines as potent and selective non steroidal CYP19 inhibitors 99
99mTc(N)-DBODC(5), a potential probe for SPECT imaging of multidrug resistance: in vitro study 98
Synthesis and characterization of novel asymmetrical M(III) (M = Re, 99gTc) complexes as models for the development of potential tracers for SPECT imaging and radiotherapy 98
Derivati fenil-pirrolochinolinonici e loro uso 87
As Nonsteroidal Aromatase Inhibitors, Azolylmethyl-pyrroloquinolines inhibit Malignant Mesothelioma Cell Proliferation 85
Azolylmethyl-pyrroloquinolines as non steroidal aromatase inhibitors 79
Approaches to the synthesis of novel bioconjugates for active targeting of potent antiproliferative phenylpyrroloquinolinones 76
Discovery of MG-2603 with in vitro potent antiproliferative activity by interfering with kinases and tubulin polymerisation 73
Discovery of a novel class of anti-proliferative pyrrolo[3,2-f]quinolin-9-ones characterized by interfering with both PI3K-Akt-mTOR signalling and microtubule assembling 73
Synthesis and Characterization of Novel Asymmetrical M(III) (M = Re, 99gTc) Complexes as Models for the Development of Potential Tracers for SPECT Imaging and Radiotherapy 72
The [Tc(N)PNP] Metal Fragment Labeled Peptide for MC1 Receptors Imaging: preliminary studies 72
Targeting of potent antiproliferative phenylpyrroloquinolinones: synthesis and preliminary biological evaluation of double prodrugs 70
In vitro and in vivo evaluation of the effects of anti-aromatase azolylmethylpyrroloquinolinones in the treatment of malignant mesothelioma 70
Synthesis of diflunisal aza-analogs quorum sensing inhibitors 69
Design, synthesis and SARs of azolylmethyl-pyrroloquinolines as non steroidal aromatase inhibitors, NPCF7 69
Evaluation of novel 1,3-diketone curcumin analogues and glycogen synthase kinase-3 betainhibitors as potential anti-inflammatory agents in glial cultures 68
SYNTHESIS AND PRELIMINARY EVALUATION OF SOME HYPOXIA-SELECTIVE PRODRUGS OF POTENT ANTIMITOTIC PHENYLPYRROLOQUINOLINONES 63
Discovery of MG-2603 with in vitro potent antiproliferative activity by interfering with kinases and tubulin polymerisation 56
Totale 6.763
Categoria #
all - tutte 21.427
article - articoli 15.318
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 366
patent - brevetti 321
selected - selezionate 0
volume - volumi 0
Totale 37.432


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021364 0 0 0 0 17 16 7 55 51 100 62 56
2021/2022615 14 97 81 27 31 25 35 58 23 13 61 150
2022/2023595 98 63 9 77 106 74 1 36 86 9 25 11
2023/2024394 45 53 46 25 42 14 33 18 11 38 35 34
2024/20251.268 19 44 54 59 199 32 53 125 96 43 212 332
2025/20261.852 240 397 539 649 27 0 0 0 0 0 0 0
Totale 6.763